Antidermatitic perspective of hydrocortisone as chitosan nanocarriers: An ex vivo and in vivo assessment using an NC/Nga mouse model

Journal of Pharmaceutical Sciences

Volumn 102, Issue 3, 2013, Pages 1063-1075

  Hussain, Zahid ^a   Katas, Haliza ^a   Amin, Mohd Cairul Iqbal Mohd ^a   Kumulosasi, Endang ^a   Sahudin, Shariza ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Allergic contact dermatitis; Biodegradable polymers; Corticosteroids; Ex vivo permeation; In vitro model; In vivo efficacy; Nanoparticles; Percutaneous

Indexed keywords

HYDROCORTISONE; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DERMATITIS; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; ERYTHEMA; EX VIVO STUDY; HISTOPATHOLOGY; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; SKINFOLD THICKNESS; WATER LOSS; WOUND HEALING; ZETA POTENTIAL;

EID: 84878157759     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23446     Document Type: Article

References (30)

1. Zöller N, Kippenberger S, Thaçi D, Mewes K, Spiegel M, Sattler A, Schultz M, Bereiter-Hahn J, Kaufmann R, Bernd A. 2008. Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model. Toxicol In Vitro 22:747-759.
2. Schoepe S, Schacke H, May E, Asadullah K. 2006. Glucocorticoid therapy-induced skin atrophy. Exp Dermatol 15:406-420.
3. Fang J, Shen K, Huang Y, Wu P, Tsai Y. 1999. Evaluation of topical application of clobetasol 17-propionate from various cream bases. Drug Dev Ind Pharm 25:7-14.
4. Fang J, Fang C, Sung K, Chen H. 1999. Effect of low frequency ultrasound on the in vitro percutaneous absorption of clobetasol 17-propionate. Int J Pharm 191:33-42.
5. Brown M, Martin G, Jones S, Akomeah F. 2006. Dermal and transdermal drug delivery systems: Current and future prospects. Drug Deliv 13:175-187.
6. Moser K, Kriwet K, Naik A, Kalia Y, Guy R. 2001. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 52:103-112.
7. Karande P, Jain A, Mitragotri S. 2004. Discovery of transdermal penetration enhancers by high-throughput screening. Nat Biotechnol 22:192-197.
8. Sammeta S, Vaka S, Murthy S. 2010. Transcutaneous electroporation mediated delivery of doxepin-HPCD complex: A sustained release approach for treatment of postherpetic neuralgia. J Control Release 142:361-367.
9. Kalia Y, Naik A, Garrison J, Guy R. 2004. Iontophoretic drug delivery. Adv Drug Deliv Rev 56:619-658.
10. Mitragotri S, Blankschtein D, Langer R. 1995. Ultrasound-mediated transdermal protein delivery. Science 269:850-853.
11. Prausnitz M. 2004. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 56:581-587.
12. Lee W, Shen S, Wang K, Hu C, Fang J. 2002. The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil. J Pharm Sci 91:1613-1626.
13. Cevc G, Vierl U. 2010. Nanotechnology and the transdermal route: A state of the art review and critical appraisal. J Control Release 141:277-299.
14. Shim J, Kang H, Park W, Han S, Kim J, Chang I. 2004. Transdermal delivery of minoxidil with block copolymer nanoparticles. J Control Release 97:477-484.
15. Alvarez-Roman R, Naik A, Kalia Y, Guy R, Fessi H. 2004. Skin penetration and distribution of polymeric nanoparticles. J Control Release 99:53-62.
16. Maia CS, Mehnert W, Schaller M, Korting H, Gysler A, Haberland A, Schafer-Korting M. 2002. Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 10:489-495.
17. Wu X, Price G, Guy RH. 2009. Disposition of nanoparticles and an associated lipophilic permeant following topical application to the skin. Mol Pharmacol 6:1441-1448.
18. He W, Guo X, Zhang M. 2008. Transdermal permeation enhancement of N-trimethyl chitosan for testosterone. Int J Pharm 356:82-87.
19. Wu W, Yang W, Wang C, Hu J, Fu S. 2005. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int J Pharm 295:235-245.
20. Papadimitriou S, Bikiaris D, Avgoustakis K. 2008. Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydr Polym 73:44-54.
21. Yamane M, Williams A, Barry B. 1995. Terpene penetration enhancers in propylene glycol-water co-solvents systems: Effectiveness and mechanism of action. J Pharm Pharmacol 47:978-989.
22. Padula C, Sartori F, Marra F, Santi P. 2005. The influence of iontophoresis on acyclovir transport and accumulation in rabbit ear skin. Pharm Res 22:1519-1524.
23. Kim T, Jung J, Kim G, Jang A, Ahn H, Park Y, Park C. 2009. Melatonin inhibits the development of 2, 4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice. J Pineal Res 47:324-329.
24. Park E, Park K, Eo H, Seo J, Son M, Kim K, Chang Y, Cho S, Min K, Jin M, Kim S. 2007. Suppression of spontaneous dermatitis in NC/Nga murine model by PG102 isolated from Actinidia arguta. J Invest Dermatol 127:1154-1160.
25. Matsuda H, Watanabe N, Geba G, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase P, Ra C. 1997. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9:461-466.
26. Avadi MR, Sadeghi AM, Mohammadpour N, Abedin S, Atyabi F, Dinarvand R, Murtaza RT. 2010. Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method. Nanomedicine 6:58-63.
27. Katas H, Hussain Z, Ling TC. 2012. Chitosan nanoparticles as a percutaneous drug delivery system for hydrocortisone. J Nanomater 2012:11 pages, doi: 10.1155/2012/327725.
28. Şenyiǧit T, Padula C, Özer Ö, Santi P. 2009. Different approaches for improving skin accumulation of topical corticosteroids. Int J Pharm 380:155-160.
29. Werner Y, Lindberg M. 1985. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol 65:102-105.
30. Gioia F, Leonardo C. 2002. The dynamics of TEWL from hydrated skin. Skin Res Technol 8:178-186.